Streetbeat News

Price Targets

CKPT

Lake Street analyst Thomas Flaten maintains a Buy rating on Checkpoint Therapeutics (NASDAQ:CKPT) but lowers the price target from $22 to $16.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 1:12 pm

ICPT

B. Riley Securities analyst Mayank Mamtani maintains a Buy rating on Intercept Pharma (NASDAQ:ICPT) but lowers the price target from $30 to $15.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 1:10 pm

ADI

JP Morgan analyst Harlan Sur maintains an Overweight rating on Analog Devices (NASDAQ:ADI) and lowers the price target from $210 to $205.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 1:10 pm

UNH

JP Morgan analyst Lisa Gill maintains an Overweight rating on UnitedHealth Group (NYSE:UNH) and lowers the price target from $595 to $562.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 1:08 pm

HUM

JP Morgan analyst Lisa Gill maintains an Overweight rating on Humana (NYSE:HUM) and lowers the price target from $625 to $576.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 1:05 pm

COP

In the last 3 months, 16 analysts have offered 12-month price targets for ConocoPhillips (NYSE:COP), with an average price target of $135.88, a decrease of 1.66% from the previous average of $138.17. The ratings include 5 bullish, 8 somewhat bullish, and 3 indifferent.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 1:04 pm

BDX

In the last 3 months, 6 analysts have offered 12-month price targets for Becton, Dickinson (NYSE:BDX), with an average price target of $284.67, a high of $304.00, and a low of $260.00. The average price target has increased by 6.22% over the past month.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 1:03 pm

CVS

JP Morgan analyst Lisa Gill maintains an Overweight rating on CVS Health (NYSE:CVS) but lowers the price target from $125 to $114.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 1:00 pm

EVLV

Northland Capital Markets analyst Michael Latimore maintains an Outperform rating on Evolv Technologies (NASDAQ:EVLV) and raises the price target from $7 to $8.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:58 pm

SLRC

Compass Point analyst Casey Alexander maintains a Neutral rating on SLR Inv (NASDAQ:SLRC) and lowers the price target from $15.75 to $14.5.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 12:58 pm